期刊文献+

细胞周期调节蛋白P16、CDK4、P53在成人和儿童髓母细胞瘤中的表达及其与预后的关系 被引量:1

Expression of Cell Cycle-modulated Proteins P16, Cyclin-dependent Kinase 4 and P53 in Adult and Childhood Medulloblastomas: Detection and Prognostic Analysis
下载PDF
导出
摘要 目的 检测细胞周期调节蛋白 P16、CDK4和 P5 3在成人和儿童髓母细胞瘤中的表达 ,并探讨其与预后的关系。方法 应用免疫组化 ABC法对 2 1例成人和 14例儿童髓母细胞瘤石蜡切片进行免疫组化检测 ,并结合随访资料进行生存曲线分析。结果 在全部 35例标本中 ,P16阳性率为 6 2 .9% ,CDK4阳性率为 10 0 % ,P5 3阳性率为 2 8.6 % ,其中 P16蛋白在成人中的表达 (16 / 2 1)要高于在儿童中的表达 (6 / 14 ) ,P5 3蛋白在成人中的表达(3/ 2 1)要低于在儿童中的表达 (7/ 14 ) ,但上述 3种蛋白的表达均与预后无关。结论  P16蛋白的表达缺失和 P5 3蛋白的异常表达可能与髓母细胞瘤的发生有关 ,但对预后无意义。儿童髓母细胞瘤的遗传学异常现象高于成人。 Objective To detect the expression of P16, cyclin dependent kinase 4 and P53 in adult and childhood medulloblastomas and the possible prognostic value thereof. Methods ABC immunohistochemistry was used to detect the expression of P16, CDK4 and P53 in the paraffin embedded medulloblastoma specimens of 21 adults and 14 children. Follow up data were obtained to perform the Kaplan Meier survival analysis. Results In the 35 cases, positive expression ratios of P16, CDK4 and P53 were 62.9%, 100% and 28.6%, respectively. The positive expression ratio of P16 in adult cases(16/21) was higher than that in childhood cases(6/14), whereas the positive expression ratio of P53 in adult cases(3/21) was lower than that in childhood cases(7/14). The expressions of P16, CDK4 and P53 had no correlation with the prognosis by Kaplan Meier survival analysis. Conclusion Deletion of P16 expression and abnormal expression of P53 might contribute to the tumorigenesis of medulloblastomas. This is apparent in childhood cases, though no prognostic value has been noted in this study. [
出处 《华西医科大学学报》 CSCD 北大核心 2002年第4期577-580,共4页 Journal of West China University of Medical Sciences
关键词 P16蛋白 细胞周期素依赖激酶4 P53蛋白 髓母细胞瘤 预后 P16 protein Cyclin dependent kinase 4 P53 protein Medulloblastoma Prognosis
  • 相关文献

参考文献16

  • 1[1]Sherr CJ. Cancer cell cycle. Science, 1996; 274:1672
  • 2[2]Sato K, Schauble B, Kleihues P, et al. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors. Int J Cancer, 1996; 66(3): 305
  • 3[3]Petronio J, He J, Fults D, et al. Common gene alterations in adult malignant astrocytoma, but not in children primitive neuroectomal tumors: p16 ink5 homozygous deletions and CDK4 gene amplification. J Neurosurg, 1996; 84(6):1020
  • 4[4]Loda M, Giangaspero F, Badiali M, et al. p53 gene expression in medulloblastoma by quantitative polymerase chain reaction. Diagn Mol Pathol, 1992; 1(1): 36
  • 5[5]Karamitopoulou E, Perentes E, Diamantis I. P53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclone antibodies. Acta Neuropathologia(Berl), 1993; 85(6): 611
  • 6[6]Jaros E, Lunec J, Perry RH, et al. P53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis. Br J Cancer, 1993; 68(4): 801
  • 7[7]Adesina AM, Dunn ST, Moore WE, et al. Expression of p27kip1 and p53 in medulloblastoma: relationship with cell proliferation and survival. Pathol Res Pract, 2000; 196(4): 243
  • 8[8]Ng HK, Lo SY, Huang DP, et al. Paraffin section P53 protein immunohistochemistry in neuroectodermal tumors. Pathol, 1994; 26(1):1
  • 9[9]Kamb A, Gruis NA, Weaver FJ, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994; 264(5157): 436
  • 10[10]Pietsch T, Scharmann T, Fonatsch C, et al. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res, 1994; 54(12): 3278

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部